Tevogen Bio Quote - TVGN

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.7928

Bid

0.76

Ask

0.7928

Volume

79,592

0.7568 Day's Range 0.79

0.00 52 Week Range 0.00

Market Cap

125.72M

Previous Close

0.7977

Open

0.789

Last Trade

100

0.7928

(formt)

Last Trade Time

17:02:15

Financial Volume

US$ 61,766

VWAP

0.77603

Average Volume (3m)

Shares Outstanding

165,421,084

Dividend Yield

PE Ratio

-1,900.00

Earnings Per Share (EPS)

-0

Revenue

Net Profit

-67k

Tevogen Bio is a leading NextGen clinical-stage specialty immunotherapy Biotech developing off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Tevogen Bio is a leading NextGen clinical-stage specialty immunotherapy Biotech developing off-the-shelf precision T cell therapeutics in virology, oncology, and neurology.

Sector

Biological Pds,ex Diagnstics

Industry

Blank Checks

Website

www.tevogen.com/

Headquarters

Wilmington, Delaware, USA

Founded

2024

Tevogen Bio Holdings Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TVGN. The last closing price for Tevogen Bio was US$0.80. Over the last year, Tevogen Bio shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Tevogen Bio currently has 165,421,084 shares outstanding. The market capitalization of Tevogen Bio is US$125.72 million. Tevogen Bio has a price to earnings ratio (PE ratio) of -1900.00.

Tevogen.AI Head Discusses Company’s Bold Strategy to Shape the Future of T Cell Therapies at Longwood Spring MIT Conference

WARREN, N.J., June 18, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing...

Tevogen Bio Set to Join Russell 3000® Index

WARREN, N.J., June 12, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing...

Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts

Includes $36 million line of credit and potential $14 million private placement WARREN, N.J., June 11, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq:...

CORRECTION – Tevogen Bio Expresses Gratitude to Patients, First Responders, Elected Officials, and Members of the United States Congress for Attending Its Inaugural Post-Public Listing Social Engagement Event

WARREN, N.J., June 07, 2024 (GLOBE NEWSWIRE) -- A release was issued under a similar headline on Thursday, June 6th by Tevogen Bio Holdings Inc. (Nasdaq: TVGN). Please note that the second...

Tevogen Bio Expresses Gratitude to Patients, First Responders, Elected Officials, and Members of the United States Congress for Attending Its Inaugural Post-Listing Social Engagement Event

WARREN, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), is a clinical-stage specialty immunotherapy company harnessing one of...

Tevogen Bio Confirms Ongoing Efficacy of TVGN 489, Its Investigational Allogeneic Off-the-Shelf Immunotherapy, Against Dominant FLiRT Strains of SARS-CoV-2

WARREN, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing...

Tevogen Bio Reports First Quarter 2024 Financial Results

Confirms liability elimination of $94.9 million and discloses $11.3 million of net incomeReports net cash used for operating activities was $2.1 millionReiterates commitment to both patients and...

Tevogen Bio Appoints Former Police Chief & FBI National Academy Graduate, William Keane, as Vice President of Strategic Initiatives

WARREN, N.J., May 16, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing...

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GRCGold Springs Resource Corp	$ 0.09 (20.00%)	255.2k
SFDNXT Energy Solutions Inc	$ 0.16 (18.52%)	118k
SAMStarcore International Mines Ltd	$ 0.14 (16.67%)	525
DSVDiscovery Silver Corp	$ 1.03 (13.19%)	913.48k
PYRPyroGenesis Canada Inc	$ 0.69 (13.11%)	191.75k
CFXCanfor Pulp Products Inc	$ 1.04 (-25.71%)	141.77k
AEZSAeterna Zentaris Inc	$ 6.04 (-24.50%)	14.45k
LPENLoop Energy Inc	$ 0.025 (-16.67%)	15.04k
ETEvertz Technologies Ltd	$ 13.30 (-13.30%)	120.44k
AABAberdeen International Inc	$ 0.035 (-12.50%)	1.61M
CNQCanadian Natural Resources Ltd	$ 47.87 (1.36%)	29.03M
TRPTC Energy Corporation	$ 52.25 (-0.08%)	14.09M
SUSuncor Energy Inc	$ 50.82 (0.08%)	8.95M
MFCManulife Financial Corporation	$ 35.23 (0.46%)	7.75M
POWPower Corp of Canada	$ 37.57 (-0.71%)	6.65M